Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure

Jacob Moller · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
heart-failurelipid-metabolismobesity
obesity, heart failure, renal function, glucose intolerance, lipid metabolism, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 893343
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.